• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.71% Nasdaq Down 0.63%

    aTyr Pharma Inc. (LIFE)

    -NasdaqGS
    3.30 Sep 23, 4:00PM EDT
    Prev Close:3.30
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:6.67
    Beta:1.41
    Earnings Date:Nov 8 - Nov 14 (Est.)
    Day's Range:N/A - N/A
    52wk Range:2.48 - 13.26
    Volume:0
    Avg Vol (3m):234,342
    Market Cap:78.27M
    P/E (ttm):N/A
    EPS (ttm):-2.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.56
    Quarterly EPS Est (Sep-16) :-0.67
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback